Delivery Order SPE2DB20D2001-SPE2DB24FPLHW

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,693.37 firm fixed-price delivery order contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,652.52 Firm Fixed Price delivery order is for the medical product "MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML" and has an ultimate completion date of January 6, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,580.89 delivery order contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has an ultimate completion date of November 7, 2024 and is a firm fixed-price arrangement. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,176.72, is a firm-fixed-price delivery order for the medical product "MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML." The contract has an ultimate completion date of December 31, 2024. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,669.00, is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product. It is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of November 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,265.08 firm fixed-price delivery order is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication. The contract has an ultimate completion date of February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,185.00 firm fixed-price delivery order is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of November 26, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,156.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of July 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,522.78 delivery order is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product, and has a completion date of December 18, 2024. The contract is a firm fixed price delivery order and was not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,615.31 firm fixed-price delivery order is for MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB24FPLHW
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,559.42 firm fixed-price delivery order is for the medical product "MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML". The contract has an ultimate completion date of September 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award is part of AmerisourceBergen's extensive federal contracting portfolio, which includes additional IDCs with agencies like the Department of Justice Federal Bureau of Investigation, demonstrating the company's critical role in supplying essential medical commodities to various federal healthcare programs.

Generated 2/27/25, 1:23 PM